Recombinant human DNase I decreases biofilm and increases antimicrobial susceptibility in staphylococci - Wikidata - awgldk - TriplyDB

Recombinant human DNase I decreases biofilm and increases antimicrobial susceptibility in staphylococci

Recombinant human DNase I decreases biofilm and increases antimicrobial susceptibility in staphylococci

http://www.wikidata.org/entity/Q35782697

about

Biologically inspired strategies for combating bacterial biofilms Non-conventional therapeutics for oral infections A Pipeline for Screening Small Molecules with Growth Inhibitory Activity against Burkholderia cenocepacia Approaches to Dispersing Medical Biofilms.Low levels of β-lactam antibiotics induce extracellular DNA release and biofilm formation in Staphylococcus aureus Life after death: the critical role of extracellular DNA in microbial biofilms.Staphylococcus aureus biofilms: recent developments in biofilm dispersal.Mycobacterium avium Possesses Extracellular DNA that Contributes to Biofilm Formation, Structural Integrity, and Tolerance to Antibiotics Biofilms in chronic rhinosinusitis: what is new and where next?Go Forth and Colonize: Dispersal from Clinically Important Microbial Biofilms.Streptokinase Treatment Reverses Biofilm-Associated Antibiotic Resistance in Staphylococcus aureus D-amino acid inhibits biofilm but not new bone formation in an ovine model.An Electrostatic Net Model for the Role of Extracellular DNA in Biofilm Formation by Staphylococcus aureus.Molecular basis of in vivo biofilm formation by bacterial pathogens Efficacy of a marine bacterial nuclease against biofilm forming microorganisms isolated from chronic rhinosinusitis.DNase inhibits Gardnerella vaginalis biofilms in vitro and in vivo.The antifungal caspofungin increases fluoroquinolone activity against Staphylococcus aureus biofilms by inhibiting N-acetylglucosamine transferase.Control of Biofilm Formation: Antibiotics and Beyond.Antimicrobial enzymes: an emerging strategy to fight microbes and microbial biofilms.Antibiofilm agents and implant-related infections in orthopaedics: where are we?Biofilm-associated infections: antibiotic resistance and novel therapeutic strategies.Efficacy and adverse effects of drugs used to treat adult cystic fibrosis.A review of the recent advances in antimicrobial coatings for urinary catheters.Bacteriophage Lysin CF-301, a Potent Antistaphylococcal Biofilm Agent.Biofilm dispersal: multiple elaborate strategies for dissemination of bacteria with unique properties.Activation of phagocytic cells by Staphylococcus epidermidis biofilms: effects of extracellular matrix proteins and the bacterial stress protein GroEL on netosis and MRP-14 release.Evaluation of combinations of putative anti-biofilm agents and antibiotics to eradicate biofilms of Staphylococcus aureus and Pseudomonas aeruginosa.Anti-biofilm properties of the antimicrobial peptide temporin 1Tb and its ability, in combination with EDTA, to eradicate Staphylococcus epidermidis biofilms on silicone catheters.Innate Immune Response in Implant-Associated Infections: Neutrophils against Biofilms.Synergistic antibiotic activity against planktonic and biofilm-embedded Streptococcus agalactiae, Streptococcus pyogenes and Streptococcus oralis.Staphylococcus aureus biofilm removal by targeting biofilm-associated extracellular proteins.Effects of prior exposure to antibiotics on bacterial adaptation to phages.Targeting polyelectrolyte networks in purulent body fluids to modulate bactericidal properties of some antibiotics.Antibiofilm Effect of DNase against Single and Mixed Species Biofilm.Biofilms of vaginal Lactobacillus reuteri CRL 1324 and Lactobacillus rhamnosus CRL 1332: kinetics of formation and matrix characterization.Temporal expression ofagrB,cidA, andalsSin the early development ofStaphylococcus aureusUAMS-1 biofilm formation and the structural role of extracellular DNA and carbohydrates Control of Biofilm Formation in Healthcare: Recent Advances Exploiting Quorum-Sensing Interference Strategies and Multidrug Efflux Pump Inhibitors Synergistic Removal of Static and Dynamic Biofilms by Combined Treatment with a Bacteriophage Endolysin and a Polysaccharide Depolymerase

P2860

Q27006003-0D7A19D5-8A88-44AE-A2F7-29E6C99FFCB8 Q28085760-57F948B3-60B8-478E-B8DB-EF36C99BD64E Q28548011-95A03E12-8697-406F-8B52-7EEF2B0F5CF8 Q33845349-D731FE8E-7DE7-4409-8784-B39358382220 Q34291700-1E47D044-1913-4657-B0D5-D5EC941AE4E7 Q34357136-EB00EFEF-CADD-40AE-BC79-59F9B8D60409 Q34763740-50F91DBE-7E2B-4E99-98D4-373CF4BFE1A7 Q35641482-5C82375A-E694-4236-92B0-561E1F3BB7E3 Q35676739-D68D3184-F0F0-4A98-B7C5-5020AACAF6D4 Q35927449-40578932-2FC0-43B9-A7AE-4B1F9789A85D Q36147148-CDCF0636-D329-4682-B2C8-CCE5D34BEE36 Q36226100-9C3CC001-6AB3-43D5-8281-F41B23F1C2F1 Q36297489-ECF0CDFD-DF09-4FCD-9C6A-B355631B32A0 Q36488561-20C45875-B854-4FB6-9CD8-54BEB4774577 Q36618443-03409C87-7B71-4A7F-9D1E-80AB4C52BABB Q36768245-A2A75101-A741-4FF8-843C-BD201FD19555 Q37396221-EB269249-CE17-4619-911B-9297EE97AD6C Q37593127-9F989145-03FD-4566-A2E3-97D06128FFE7 Q38071062-E888C62F-9442-495F-BBC5-1C6212497133 Q38107655-A1441A8E-495C-4C0C-9900-87EE18380741 Q38120559-BB442639-5EB1-4595-B2BD-0F32B85908F7 Q38325672-DF6E59B4-EB7E-47DE-80EB-4111D829CE89 Q38787366-528C8A80-CF8A-494C-9EE5-6CEF2D1D5FE3 Q38810296-A5A63607-C0D0-4722-B50A-F36B707B1C9D Q39250412-97E8C63D-CCC8-4742-9CCC-4D903D34B4BC Q39826305-3D39B9B2-7D13-444B-BD92-A2EC11BB9A3E Q40072216-04F244ED-B12C-47E7-A4AD-CF660468CB46 Q40633893-73897D73-5AAD-4666-AB1F-293BD9DB5753 Q40674697-88562DDA-A77B-4754-943E-F421DCC02C8C Q46298742-BCF3E6A7-27F9-4538-BD9D-4423FAF0E3A1 Q47134059-D9B6A032-8383-422F-90F5-90552CDE0619 Q47567998-31E2670D-DA6F-4A2A-91ED-AE8E63B7B5F2 Q49387443-4DE27142-055F-4AD5-9C0A-A10D054B3D06 Q51737041-C153EA85-4D3E-4A34-A146-A0341B0F87CB Q53110403-A3F56AD1-9314-419E-9630-53CC2831D073 Q58216977-A056E9E0-9084-45D6-99F4-69F4C4DF91A2 Q58753420-9334A2B2-30EF-4F8F-87E8-8C582BF380CD Q58766750-E5CA787B-AF75-4A77-B423-80E81C6521DF

P2860

Recombinant human DNase I decreases biofilm and increases antimicrobial susceptibility in staphylococci

http://www.wikidata.org/entity/Q35782697

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Recombinant human DNase I decr ...... usceptibility in staphylococci

@ast

Recombinant human DNase I decr ...... usceptibility in staphylococci

@en

type

label

Recombinant human DNase I decr ...... usceptibility in staphylococci

@ast

Recombinant human DNase I decr ...... usceptibility in staphylococci

@en

prefLabel

Recombinant human DNase I decr ...... usceptibility in staphylococci

@ast

Recombinant human DNase I decr ...... usceptibility in staphylococci

@en

P1433

Q35782697-BF51B2DF-F1A2-4B34-BEAE-4D38181AFC65

P1476

Q35782697-479227DC-8ED8-44F4-926C-E75B6679CC9E

P2093

Q35782697-0549C25A-507D-4539-B062-B271ED8A2DB8

Q35782697-59F69470-26D6-4D8B-9223-DBD71EEAD6EC

Q35782697-5FF5F287-0AFE-4694-BB4D-4A7BF90FEE42

Q35782697-6D4CF4EE-5855-4D46-82A1-B911F41B4288

Q35782697-999EDA37-8B73-4E38-B1B3-AC51333C68F4

Q35782697-DBE3DDC0-A3C3-4288-9E77-6C8D4CAF6E99

Q35782697-FBE9D738-6027-4CE1-A9D9-5FCF9FF8D9B9

P2860

Q35782697-04CAF36A-3F32-4EA6-8C44-BBAE4B3DB542

Q35782697-09DD2758-2F0D-4DF5-B608-C47FFF2745CC

Q35782697-153441BB-3458-466C-9530-D1173409FDA1

Q35782697-1E6DA917-1AFB-4129-9176-9E8F33475FF0

Q35782697-203BDBD4-A5C9-49D2-B38F-7D539BF8BE3B

Q35782697-31B44FD4-807B-4558-8922-9E22D235008C

Q35782697-35DEAD73-9236-4721-9A90-1DBEBAFAEB42

Q35782697-57C77D81-B310-4870-AD54-736EDF48E8C6

Q35782697-5B40177E-F7F8-4948-94C9-D4EF89A8C9DD

Q35782697-5EDCB03E-535A-48A4-A2DA-ED04F8C330DB

P2888

Q35782697-F68A2DEC-DEF8-4C13-AF9A-AC4F4DA6F1B4

P304

Q35782697-63979DF1-5E02-4B64-B895-48100B80A871

P31

Q35782697-FB5295C3-BA69-4DD0-9A3B-83B2E287A9BD

P356

Q35782697-74A3C4F4-7380-4A5A-8B32-ACD0A2DDD17C

P433

Q35782697-522AFFBA-F3FB-48A8-B94A-0058C9042829

P478

Q35782697-034C58F6-2CF3-4207-A606-C1F47129CD81

P577

Q35782697-58F949A7-213F-42E0-9437-2944B4096224

P5875

Q35782697-FE7CE768-A5E7-45A6-A15E-2063360D7CAA

P6179

Q35782697-AD6B0361-1CC6-41D3-86FA-3BA7C4BB9B10

P698

Q35782697-51DD6963-E56D-431D-8AB1-DFC310B85A39

P921

Q35782697-3984ABB5-3A59-440C-A12D-DD2B02E36F32

P932

Q35782697-0A83B7E6-C110-4874-A38D-C893C3A11363

P356

P1433

The Journal of Antibiotics

P1476

Recombinant human DNase I decr ...... usceptibility in staphylococci

@en

P2093

Era A Izano

http://www.w3.org/2001/XMLSchema#string

Irina Sadovskaya

http://www.w3.org/2001/XMLSchema#string

Jeffrey B Kaplan

http://www.w3.org/2001/XMLSchema#string

Karen LoVetri

http://www.w3.org/2001/XMLSchema#string

Saïd Jabbouri

http://www.w3.org/2001/XMLSchema#string

Silvia T Cardona

http://www.w3.org/2001/XMLSchema#string

Srinivasa Madhyastha

http://www.w3.org/2001/XMLSchema#string

P2860

Extracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilms

Extracellular DNA Required for Bacterial Biofilm Formation

Biofilms: microbial life on surfaces

Differential roles of poly-N-acetylglucosamine surface polysaccharide and extracellular DNA in Staphylococcus aureus and Staphylococcus epidermidis biofilms

Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-actin and DNA as targets for therapy

Whole genome sequencing of meticillin-resistant Staphylococcus aureus

The biofilm matrix

Identification of novel antimicrobials using a live-animal infection model

Characterization of biofilm matrix, degradation by DNase treatment and evidence of capsule downregulation in Streptococcus pneumoniae clinical isolates.

Gene transfer occurs with enhanced efficiency in biofilms and induces enhanced stabilisation of the biofilm structure.

P2888

P304

73-77

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/JA.2011.113

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51876258

http://www.w3.org/2001/XMLSchema#string

P6179

1001451482

http://www.w3.org/2001/XMLSchema#string

P698

22167157

http://www.w3.org/2001/XMLSchema#string

P921

P932

3288126

http://www.w3.org/2001/XMLSchema#string